Home › Research › Prevention and risk
Dementia and hearing loss: from risk to mechanisms and management
Emma Elizabeth Broome, Sian Calvert, Eithne Heffernan, Helen Henshaw, A Khan, Vassilis Pelekanos, Joseph Sollini, Jack Stancel-Lewis et al.. Frontiers in Dementia, 2026-02-17
Topic: Risk, prevention and care in population studies
Plain-language summary
Hearing loss in midlife is an important and potentially modifiable risk factor for the development of dementia. Research examining the association between dementia and hearing loss has expanded rapidly; however, evidence for the mechanisms linking the two conditions is inconclusive, limiting the development of targeted interventions. This review provides a critical overview of current evidence on dementia risk in relation to hearing loss, proposed mechanisms underpinning this association, and emerging evidence on the effectiveness of hearing interventions in modifying trajectories of cognitive decline, dementia risk, and disease progression. Alongside its role as a risk factor, hearing loss commonly co-occurs with dementia, highlighting the need for integrated approaches to care that address the considerable impact of these co-morbid conditions on individuals and communities. Finally, we emphasise the importance of including diverse populations in future research to improve generalisability of findings and help advance equity in dementia prevention and care.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Broome, E. E., Calvert, S., Heffernan, E., Henshaw, H., Khan, A., Pelekanos, V., et al. (2026). Dementia and hearing loss: from risk to mechanisms and management. Frontiers in Dementia. https://doi.org/10.3389/frdem.2026.1736003
Vancouver
Broome EE, Calvert S, Heffernan E, Henshaw H, Khan A, Pelekanos V, et al. Dementia and hearing loss: from risk to mechanisms and management. Frontiers in Dementia. 2026. doi:10.3389/frdem.2026.1736003. PMID: 41783253.
BibTeX
@article{broome2026-41783253,
author = {Broome, Emma Elizabeth and Calvert, Sian and Heffernan, Eithne and Henshaw, Helen and Khan, A and Pelekanos, Vassilis and Sollini, Joseph and Stancel-Lewis, Jack and others},
title = {{Dementia and hearing loss: from risk to mechanisms and management}},
journal = {Frontiers in Dementia},
year = {2026},
doi = {10.3389/frdem.2026.1736003},
pmid = {41783253},
url = {https://doi.org/10.3389/frdem.2026.1736003}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Hearing loss in midlife is an important and potentially modifiable risk factor for the development of dementia.
- Research examining the association between dementia and hearing loss has expanded rapidly; however, evidence for the mechanisms linking the two conditions is inconclusive, limiting the development of targeted interventions.
- This review provides a critical overview of current evidence on dementia risk in relation to hearing loss, proposed mechanisms underpinning this association, and emerging evidence on the effectiveness of hearing interventions in modifying trajectories of cognitive decline, dementia risk, and disease progression.
- Alongside its role as a risk factor, hearing loss commonly co-occurs with dementia, highlighting the need for integrated approaches to care that address the considerable impact of these co-morbid conditions on individuals and communities.
- Finally, we emphasise the importance of including diverse populations in future research to improve generalisability of findings and help advance equity in dementia prevention and care.
Why it matters
This review states that hearing loss in midlife is an important and potentially modifiable risk factor for dementia, but that evidence for the mechanisms linking the two is inconclusive. It notes emerging but not yet settled evidence on whether hearing interventions change cognitive decline or dementia risk.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Evidence strengthLow
How this study scored 42/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Frontiers in Dementia) |
| Journal's citation record | 0 / 4 | Frontiers in Dementia: journal h-index 13 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 5 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.5 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 5 / 6 | Cited 22.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 5 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Tom Dening: h-index 52 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Nottingham: institution h-index 879 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41783253) |
| Free to read | 2 / 2 | Free to read |
| Total | 42 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.3389/frdem.2026.1736003
- PubMed: 41783253
- Original source →
- Free full text: Frontiers in Dementia →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 25.
Related studies in Prevention and risk from nearby years
Also tagged “prevalence”
1,223 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,223 tagged studies.